Aromatase inhibitors (AIs) are a class of medications that play a critical role in the treatment of hormone receptor-positive breast cancer, primarily in postmenopausal women. They work by blocking the aromatase enzyme, which converts androgens into estrogens, thereby reducing estrogen levels in the body. Lower estrogen levels can help slow or stop the growth of hormone-sensitive tumors.
https://ushornbill.thedigitalclicks.com/understanding-aromatase-inhibitors-a-comprehensive-guide/
Aromatase inhibitors are typically prescribed to estrogen receptor-positive (ER+) breast cancer patients, particularly after surgery or during adjuvant therapy. The main types of AIs include:
AIs are primarily intended for:
The benefits of aromatase inhibitors in breast cancer treatment include:
While aromatase inhibitors are effective in treating breast cancer, they are not without potential side effects. Common side effects may include:
Aromatase inhibitors are a vital component of breast cancer treatment that targets hormone-sensitive tumors by lowering estrogen levels in the body. Given their specific roles, it is crucial for patients to consult their healthcare providers to determine whether AIs are suitable for their treatment plans. Understanding the implications, benefits, and risks associated with these medications will empower patients on their journey towards recovery.